Table 2.
List of patients for peripheral blood NK cell analyses.
Patients | Clinical diagnosis | Gender | Site of onset | Disease duration | Score |
---|---|---|---|---|---|
1 | sALS | F | Spinal | 18 | C |
2 | sALS | M | Spinal | 9 | A |
3 | sALS | F | Spinal | 16 | A |
4 | sALS | M | Bulbar | 7 | C |
5 | sALS | F | Spinal | 98 | B |
6 | sALS | M | Bulbar | 8 | A |
7 | sALS | F | Spinal | 39 | C |
8 | sALS | M | Bulbar | 44 | C |
9 | sALS | M | Bulbar | 22 | C |
10 | sALS | F | Spinal | 24 | A |
11 | sALS | M | Spinal | 25 | B |
12 | sALS | M | Spinal | 50 | C |
14 | sALS | M | Bulbar | 16 | B |
15 | sALS | F | Bulbar | 12 | C |
Site of onset (region in which first symptoms occurred): bulbar onset, spinal onset.
ALS Amyotrophic lateral sclerosis, sALS sporadic ALS, M male, F female.
Disease duration: months from diagnosis to blood sample. Score: ALS patient deficit was scored according to the following scale: A—moderate; B—medium-severe; C—severe; D—complete. The age of ALS patients was 58.37 ± 3.2 years. Healthy donors were recruited between 50.26 ± 10.2 years, of different gender (n = 14).